Professor Debby Mangelings from the Vrije Universiteit in Belgium, estimates that 60% of newly commercialized drugs possess chiral properties. In this interview with Bethany Degg of The Column, Mangelings discusses the importance of chiral chromatography in pharmaceutical analysis, the challenges of current methods, and where the field is heading next.
Professor Debby Mangelings from the Vrije Universiteit in Belgium, estimates that 60% of newly commercialised drugs possess chiral properties. In this interview with Bethany Degg of The Column, Mangelings discusses the importance of chiral chromatography in pharmaceutical analysis, the challenges of current methods, and where the field is heading next.
Leveraging an Enterprise Laboratory Informatics Platform to Maximize Scientific Data Advantage
September 9th 2024As data volumes and expectations for fast scientific discovery continue to increase, laboratory-based research organizations can no longer rely on a siloed approach to data management. To remain competitive, scientific organizations need to connect all their data, from discovery through manufacturing, in a unified informatics platform.